Differentiated Platform Technology
AuraVax uses a differentiated approach including the following:
Mucosal immunity
Stopping COVID-19 at the “doorstep”: Immunity in the nasal and respiratory comparments
Comprehensive immunity
Rapid and durable activation of all phases of the immune system (IgA, IgG and T cells)
Prevent COVID-19 dissemination
Within the individual and across individuals and amenable to broad distribution
Vaccine compliance and distribution
Designed for painless self-administration and avoids cold chain logistics
Comprehensive COVID-19 Immunity Mechanism
